This is a StreetInsider.com Premium Only Page

(DTIL) – StreetInsider.com Reports

Apr 1, 2024 06:54 AM Precision BioSciences Inc. (DTIL) PT Raised to $60 at H.C. Wainwright

Mar 20, 2024 12:37 PM Precision BioSciences (DTIL) PT Raised to $30 at Jones Trading adjusting for reverse stock split

Mar 19, 2024 07:01 AM Precision BioSciences (DTIL) Presents Preclinical Data Highlighting PBGENE-PMM as a Potential Therapy for Primary Mitochondrial Myopathy

Mar 6, 2024 08:45 AM Precision BioSciences (DTIL) Announces MHRA Approval for Partner iECURE to Expand Phase 1/2 Clinical Trial

Mar 1, 2024 06:31 AM Precision BioSciences (DTIL) Announces 2.5M Share Offering at $16/sh

Feb 29, 2024 04:01 PM Precision BioSciences (DTIL) Announces Proposed Public Offering of Common Stock and Warrants

Feb 20, 2024 07:10 AM Precision BioSciences (DTIL) Announces Non-Exclusive Patent License Agreement with Caribou Biosciences

Feb 14, 2024 07:01 AM Precision BioSciences (DTIL) Receives Pre-IND Feedback from US FDA for PBGENE-HBV

Feb 12, 2024 07:02 AM Precision BioSciences (DTIL) Receives $7.5M Payment and Equity Investment from TG Therapeutics (TGTX) over Azel-Cel

Feb 9, 2024 07:00 AM Precision BioSciences (DTIL) Announces 1:30 Reverse Share Split

Jan 9, 2024 07:03 AM Precision BioSciences (DTIL) Completes License Deal with TG Therapeutics (TGTX) for Cell Therapy Azer-Cel

Dec 13, 2023 08:20 AM Precision BioSciences (DTIL) Announces Approval of Clinical Trial Application of ARCUS Gene Insertion Program by Partner iECURE

Nov 13, 2023 07:05 AM Precision BioSciences (DTIL) Presents Late-Breaking Data Highlighting Preclinical Efficacy and Safety of PBGENE-HBV for Chronic Hepatitis B

Nov 8, 2023 08:07 AM Precision BioSciences Inc. (DTIL) PT Lowered to $3 at BMO Capital

Nov 7, 2023 07:06 AM Precision BioSciences (DTIL) Tops Q3 EPS by 12c

Sep 27, 2023 07:03 AM Precision BioSciences (DTIL) Receives U.S. Patent Allowance Covering PBGENE-PMM for m.3243-Associated Mitochondrial Diseases

Aug 17, 2023 06:43 AM Precision BioSciences Inc. (DTIL) PT Lowered to $3 at H.C. Wainwright

Aug 16, 2023 07:11 AM Precision BioSciences (DTIL) Completes Strategic Transaction with Imugene for Azer-Cel in Cancer

Aug 4, 2023 08:13 AM Precision BioSciences (DTIL) Tops Q2 EPS by 15c

Jul 31, 2023 06:50 AM Precision BioSciences Inc. (DTIL) PT Lowered to $5 at H.C. Wainwright

Jul 28, 2023 09:06 AM Precision BioSciences Inc. (DTIL) PT Lowered to $1.40 at Stifel

Jul 28, 2023 04:22 AM Precision BioSciences Inc. (DTIL) PT Lowered to $2 at BTIG

Jul 27, 2023 07:31 AM Precision BioSciences (DTIL) Provides Updates on Azer-Cel FDA Meeting

Jun 9, 2023 08:39 AM Precision BioSciences (DTIL) Files $250M Mixed Shelf

May 31, 2023 07:32 AM Precision BioSciences (DTIL) Provides Update on Allogeneic CAR T Programs and Regulatory Path Forward

May 19, 2023 07:00 AM Precision BioSciences (DTIL) Presents Preclinical Data Demonstrating Potential of ARCUS

May 15, 2023 05:34 AM Precision BioSciences (DTIL) Reports Publication of Preclinical In Vivo Gene Editing Abstract

May 9, 2023 07:54 AM Precision BioSciences (DTIL) Tops Q1 EPS by 1c

Apr 13, 2023 07:03 AM Precision BioSciences (DTIL) Granted US and International Patent Allowances for Proprietary PCSK9 ARCUS Nuclease

Mar 13, 2023 04:06 PM BMO Capital Downgrades Precision BioSciences Inc. (DTIL) to Market Perform

Mar 9, 2023 01:48 PM Precision BioSciences Inc. (DTIL) PT Lowered to $7 at Stifel

Mar 9, 2023 07:08 AM Precision BioSciences (DTIL) Misses Q4 EPS by 6c

Feb 24, 2023 07:01 AM Precision BioSciences (DTIL) Announces Senior Leadership Promotions and Organizational Changes

Nov 10, 2022 05:03 PM Precision BioSciences (DTIL) Announces Board Changes

Nov 10, 2022 06:48 AM Precision BioSciences Inc. (DTIL) PT Lowered to $17 at H.C. Wainwright

Nov 10, 2022 03:27 AM Precision BioSciences Inc. (DTIL) PT Lowered to $1 at Goldman Sachs

Aug 9, 2022 08:14 AM Precision BioSciences Inc. (DTIL) PT Lowered to $9 at Stifel

Aug 8, 2022 07:04 AM Precision BioSciences (DTIL) Misses Q2 EPS by 2c

Jun 22, 2022 08:21 AM Precision's (DTIL) Novartis Deal 'Adds Validation' While Financing Could Improve Sentiment, Analyst Says

Jun 22, 2022 06:13 AM Stifel Reiterates Buy Rating on Precision BioSciences (DTIL) Over Equity Raise; Novartis Deal Could Net "Up to $1.4B"

Jun 22, 2022 05:47 AM Precision BioSciences (DTIL) Prices 35.97M Share Offering at $1.39/sh

Jun 21, 2022 05:07 PM Precision BioSciences (DTIL) Surges 110% Following Pact with Novartis (NVS)

Jun 21, 2022 05:00 PM Precision BioSciences (DTIL) Announces In Vivo Gene Editing Collaboration with Novartis (NVS) to Develop Potentially Curative Treatment for Disorders Including Sickle Cell Disease

Jun 16, 2022 04:14 PM UPDATE: BMO Capital Starts Precision BioSciences Inc. (DTIL) at Outperform

Jun 9, 2022 04:10 AM William Blair Downgrades Precision BioSciences Inc. (DTIL) to Market Perform

Jun 8, 2022 04:39 PM "Updated PBCAR0191 Efficacy Looks Compelling" - Stifel Reiterates Buy Rating on Precision BioSciences (DTIL) with $16 Price Target

Jun 8, 2022 07:05 AM Precision BioSciences (DTIL) Provides Update on Allogeneic CAR T Programs and Path Forward with Its Lead PBCAR0191 Candidate

May 18, 2022 07:08 AM Precision BioSciences (DTIL) Reports Publication of ARCUS In Vivo Gene Editing as a Promising Therapeutic Approach to Cure Chronic Hepatitis B Infection

May 16, 2022 07:11 AM Precision BioSciences (DTIL) Reports Preclinical Data Showcasing Premier In Vivo Gene Editing Capabilities

May 10, 2022 03:20 PM Precision BioSciences Inc. (DTIL) PT Lowered to $10 at Jones Trading